We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current KTTA market cap is 3.48M. The company's latest EPS is USD -12.6040 and P/E is -0.23.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.79M | -5.15M | -4.04M | -3.94M | -3.01M |
| Net Income | -3.61M | -5.05M | -3.86M | -3.87M | -3M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 15k | 487k | 0 |
| Operating Income | -41k | -4.51M | -14.82M | -15.98M |
| Net Income | -41k | -2.17M | -13.94M | -15.96M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 30.66M | 26.12M | 22.41M | 17.66M | 18.64M |
| Total Liabilities | 2.28M | 2.72M | 2.53M | 1.49M | 824k |
| Total Equity | 28.37M | 23.4M | 19.88M | 16.18M | 17.81M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 248k | 53.32M | 45.18M | 26.12M |
| Total Liabilities | 7k | 1.9M | 2.68M | 2.72M |
| Total Equity | 241k | 51.42M | 42.5M | 23.4M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -10.11M | -13.43M | -4.32M | -8.36M | -11.48M |
| Investing | 344k | 398k | N/A | N/A | N/A |
| Financing | -3.73M | -3.73M | N/A | N/A | 4.54M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -38k | -3.17M | -14.56M | -13.43M |
| Investing | N/A | -22k | -2.06M | 398k |
| Financing | 282k | 55.93M | -3.21M | -3.73M |
| Market Cap | 3.48M |
| Price to Earnings Ratio | -0.23 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.23 |
| Price to Book Ratio | 0.16 |
| Dividend Yield | - |
| Shares Outstanding | 1.27M |
| Average Volume (1 week) | 91.29k |
| Average Volume (1 Month) | 33.24k |
| 52 Week Change | -62.84% |
| 52 Week High | 9.25 |
| 52 Week Low | 2.37 |
| Spread (Intraday) | 0.21 (7.09%) |
| Company Name | Pasithea Therapeutics Corporation |
| Address |
8 the green ste a dover, delaware 19901 |
| Website | https://www.pasithea.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
